The present invention relates generally to tissue treatment systems and in particular to systems and methods for collecting wound fluid.
Clinical studies and practice have shown that providing a reduced pressure in proximity to a compromised tissue site augments and accelerates the growth of new tissue at the tissue site. The applications of this phenomenon are numerous, but application of reduced pressure has been particularly successful in treating wounds. This treatment (frequently referred to in the medical community as “negative pressure wound therapy,” “reduced pressure therapy,” or “vacuum therapy”) provides a number of benefits, including faster healing and increased formulation of granulation tissue. Typically, reduced pressure is applied to tissue through a porous pad or other manifold device. The porous pad contains cells or pores that are capable of distributing reduced pressure to the tissue and channeling fluids that are drawn from the tissue.
Wound fluids, also known as exudates, are generally collected in a canister for disposal or analysis. Wound fluid primarily consists of plasma in addition to red and white blood cells, platelets, bacteria, and a variety of proteinaceous material. Plasma consists primarily of saline. In clinical practice, it is desirable that canisters are sized large enough to obviate the need for frequent replacement even when used in the treatment of wounds generating a high volume of exudate. Conversely, it is also desirable that the canister is not so bulky that the canister consumes too much storage space or unnecessary resources for hazardous waste disposal of canisters filled with potentially infectious wound fluid. In the home healthcare environment, storage and disposal issues are more pronounced. Caregivers in the home environment must also supply a bodily with empty canisters and dispose of filled canisters, so minimizing this burden and potential accidents resulting from the disposal of filled containers is useful as well as more cost-effective.
In an illustrative embodiment, a bodily fluid collection canister intended for use with a reduced pressure treatment unit wherein the canister comprises a generally rigid support member with a proximal end and a distal end. The proximal end includes an inlet and an outlet. The inlet is adapted to receive bodily fluids from a tissue site and the outlet is adapted to receive reduced pressure from a reduced pressure treatment unit. The support member is releasably connectable to the reduced pressure treatment unit. The canister also comprises a container having walls wherein the walls define a chamber. The container comprises a proximal end that includes an inlet to receive bodily fluids from a tissue site and an outlet to receive reduced pressure from a reduced pressure therapy unit. The container comprises a closed distal end. The walls of the container have a collapsible portion that allows the container to be compressed or collapsed and stretched or expanded. The canister also comprises a retention device to couple the distal end of the container to the distal end of the support member, holding the container in an expanded state.
In another illustrative embodiment, a bodily fluid collection canister intended for use with a reduced pressure treatment unit, the canister comprising a support member whose body is essentially rigid, a proximal end and a distal end. The proximal end includes an inlet to receive fluid from a tissue site and an outlet configured to receive reduced pressure via a fluid coupling. The support member is configured to be releasably connectable to the reduced pressure treatment unit. The canister also comprises a container with walls, the walls defining a chamber within the container. The canister includes a proximal end and a distal end. The proximal end includes an opening to the chamber fluidly connected to the inlet and outlet of the support member. The distal end of the container is closed, closing the chamber. The walls of the container comprise a collapsible portion that allows the container to be compressed or collapsed and stretched or expanded. The container also comprises a fluidic device such as a bladder or a pneumatic pouch located within the container. The fluidic device is adapted to be charged or filled with a fluid, either gaseous or liquid, such that when charged, the container is essentially stretched or expanded until the fluidic device is discharged.
In still another embodiment, a method for collecting bodily fluid from a tissue site is provided. The method may include expanding a canister from one volume to a greater volume and affixing the canister to a carrier plate. The method may include expanding a canister from one volume to a greater volume and charging a fluidic device that is integral to the canister such that the charged fluidic device substantially maintains the expanded state of the canister. The method may further include applying a reduced pressure to the canister such that bodily fluid is collected from the tissue site.
In the following detailed description of several illustrative embodiments, reference is made to the accompanying drawings that form a part hereof, and in which is shown by way of illustration specific preferred embodiments in which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is understood that other embodiments may be utilized and that logical structural, mechanical, electrical, and chemical changes may be made without departing from the spirit or scope of the invention. To avoid detail not necessary to enable those skilled in the art to practice the embodiments described herein, the description may omit certain information known to those skilled in the art. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the illustrative embodiments are defined only by the appended claims.
The term “reduced pressure” as used herein generally refers to a pressure less than the ambient pressure at a tissue site that is being subjected to treatment. In most cases, this reduced pressure will be less than the atmospheric pressure at which the bodily is located. Alternatively, the reduced pressure may be less than a hydrostatic pressure associated with tissue at the tissue site. Although the terms “vacuum” and “negative pressure” may be used to describe the pressure applied to the tissue site, the actual pressure reduction applied to the tissue site may be significantly less than the pressure reduction normally associated with a complete vacuum. Reduced pressure may initially generate fluid flow in the area of the tissue site. As the hydrostatic pressure around the tissue site approaches the desired reduced pressure, the flow may subside, and the reduced pressure is then maintained. Unless otherwise indicated, values of pressure stated herein are gauge pressures. Similarly, references to increases in reduced pressure typically refer to a decrease in absolute pressure, while decreases in reduced pressure typically refer to an increase in absolute pressure.
The term “tissue site” as used herein refers to a wound or defect located on or within any tissue, including but not limited to, bone tissue, adipose tissue, muscle tissue, neural tissue, dermal tissue, vascular tissue, connective tissue, cartilage, tendons, ligaments, or parenchymatous tissue. The term “tissue site” may further refer to areas of any tissue that are not necessarily wounded or defective, but are instead areas in which it is desired to add or promote the growth of additional tissue.
Referring to
The wound dressing 110 may further comprise a drape 118 adapted to cover the distribution manifold 116 for providing a substantially airtight seal over the tissue site 112 to maintain the reduced pressure at various desired levels. The drape 118 may include an adhesive seal (not shown) that not only maintains of the reduced pressure at various levels, but also holds the wound dressing 110 in place over the tissue site 112. The distribution manifold 116 may be a bioabsorbable or bioinert material capable of distributing reduced pressure to the tissue site 112. In one embodiment, the distribution manifold 116 may be an open cell, reticulated foam comprising, for example, a polyurethane material. The wound dressing 110 delivers reduced pressure to a tissue site 112 to provide therapeutic treatment to the tissue site 112 and collect exudates and bodily fluids 113 from the tissue site 112.
The reduced pressure treatment unit 101 may comprise a reduced pressure source (not shown) having an inlet port 107 and a processing unit (not shown) for controlling various features of the reduced pressure treatment unit 101. The inlet port 107 of the reduced pressure source may be fluidly coupled to the outlet 106 of the canister 102 for providing reduced pressure to the flexible container 104 of the canister 102. The reduced pressure source may be a reduced pressure or vacuum pump driven by a motor. In another embodiment, the reduced pressure source may be a manually-actuated pump such as a compressible bellows pump. In still another embodiment, the reduced pressure source may be a wall suction port either with or without a separate pressure regulator.
The reduced pressure source and the processing unit may both be housed within the reduced pressure treatment unit 101 which may also contain sensors, processing units, alarm indicators, memory, databases, software, display units, and user interfaces that further facilitate the application of reduced pressure treatment to the tissue site. In one example, a sensor (not shown) may be disposed at or near the reduced pressure source to determine a source pressure generated by the reduced pressure source. The sensor may communicate with the processing unit that monitors and controls the reduced pressure delivered by the reduced pressure source.
In one embodiment, the container 104 comprises walls 120 that form a chamber within the container 104, a proximal end 122 including an opening 123 to the chamber, and a distal end 124 that is closed. The opening 123 may be fluidly coupled to the inlet 105 and the outlet 106 of the canister 102. The walls 120 may have a collapsible portion that allows the container 104 to be compressed to an empty volume and expanded to a filled volume (the filled volume being greater than the empty volume). It is desirable that the walls 120 have a collapsible portion so that containers 104 when empty can be stored and shipped in a collapsed state of the empty volume to reduce the space consumed. When the canister 102 is snapped into place on the reduced pressure treatment unit 101 prior to being used, a caregiver may expand or stretch the walls 120 outwardly from the collapsed state to an expanded state to allow the container 104 to be filled with wound fluids 113 when reduced pressure is applied.
In one embodiment, the collapsible portion of the walls 120 may be corrugated such that the walls 120 are formed from reticulations 121 comprising a series of generally parallel grooves and ridges that fold down on each other in a direction generally perpendicular to the reticulations 121. The walls 120 may also have a non-corrugated or rigid portion adjacent the opening 123 to provide structure for fluidly coupling the opening 123 within the canister 102. The walls 120 may also have a non-corrugated or rigid portion that provides a pocket 125 adjacent the distal end 124 that may contain gelling agents used to solidify the wound fluids 113 contained within the container 104. In another embodiment, the collapsible portion of the walls 120 may be formed from reticulations 121 having gradually increasing or decreasing diameters so that the walls 120 collapse telescopically around each other rather than folding down on top of each other.
The carrier plate 103 of the canister 102 may be, for example, a thermoplastic plate that supports the container 104 and is releasably connectable to the reduced pressure treatment unit 101. The outlet 106 of the canister 102 is fluidly coupled to the inlet port 107 of the reduced pressure treatment unit 101 when the carrier plate 103 is connected to the reduced pressure treatment unit 101. The carrier plate 103 may include a set of apertures 127 at the proximal end of the carrier plate 103 through which the outlet 106 of the canister 102 may be fluidly coupled to the reduced pressure treatment unit 101 including the inlet port 107. The apertures 127 allow the canister 102 to be fluidly coupled to the reduced pressure treatment unit 101 without contaminating the carrier plate 103 with bodily fluids 113 and exudates drawn from the tissue site 112. The carrier plate 103 may be connected to the reduced pressure treatment unit 101 by a plurality of connection devices such as, for example, latches 128 that are formed on the carrier plate 103 such that the latches 128 mate with and eject from the reduced pressure treatment unit 101 by pushing the carrier plate 103 into position on the reduced pressure treatment unit 101 and then releasing the latches 128 to remove the carrier plate 103. Other types of connection systems may be used to hold the carrier plate 103 in position facilitating removal of the carrier plate 103 from the reduced pressure treatment unit 101. In another embodiment, the carrier plate 103 may be affixed to the reduced pressure treatment unit 101.
The carrier plate 103 further comprises a retaining means or a retention device to ensure that the collapsible portion of the walls 120 does not compress or collapse under atmospheric pressure when reduced pressure is applied to the tissue site 112 by the reduced pressure treatment unit 101 and ultimately applied to the chamber of the container 104. In one embodiment, the retention device may be formed at the distal end of the carrier plate 103 for coupling to the distal end 124 of the container 104 when the walls 120 are stretched to the expanded state as described above. The retention device may be, for example, at least one boss having a male boss portion 130 extending from the carrier plate 103 and a female boss portion 131 in the container 104 for receiving the male boss portion 131 which holds the walls 120 of the container 104 in the extended state when reduced pressure is being applied to the tissue site 112 and ultimately to the chamber of the container 104.
In operation, the container 104 is packaged in its collapsed state to reduce the volume of the container 104 when packaged for shipping. When the caregiver opens the package containing the container 104 and connects the opening 123 of the container 104 to the carrier plate 103, the caregiver may then draw the distal end 124 of the container 104 down to the distal end of the carrier plate 103 stretching the walls 120 into the expanded state and may hook the female boss portion 131 of the container 104 to the male boss portion 130 of the carrier plate 103 to hold or retain the container 104 in the expanded state when reduced pressure is being applied to the tissue site 112 and the canister 102. The retention device may be implemented by other embodiments to ensure that the collapsible portion of the walls 120 does not collapse under atmospheric pressure.
In another embodiment, the retention device may include a coiled spring 150 positioned within the chamber of the container 104 as shown in
In yet another embodiment shown in
In still another embodiment shown in
In another embodiment, the canister 102 may further comprise a fluid interface member such as, for example, an interface connector 140. Referring more specifically to
A method for collecting bodily fluids from a tissue site is provided according to an illustrative embodiment. The method includes expanding a canister having a variable volume from a first volume to a second volume, the second volume being greater than the first volume. The method may further comprise affixing the canister to a carrier plate, whereby the volume of the canister is maintained substantially at the second volume. The method may further comprise releasing a retainer on a spring disposed within the canister, whereby the spring maintains the volume of the canister substantially at the second volume. The method may further comprise charging a fluidic device disposed within the canister with a fluid such that the fluidic device becomes substantially rigid and whereby the volume of the canister is maintained substantially at the second volume. The method further includes creating a reduced pressure within the canister to draw bodily fluids from the tissue site to the canister.
It should be apparent from the foregoing that an invention having significant advantages has been provided. While the invention is shown in only a few of its forms, it is not just limited but is susceptible to various changes and modifications without departing from the spirit thereof.
The present invention claims the benefit, under 35 USC § 119(e), of the filing of U.S. Provisional Patent Application Ser. No. 61/780,056, entitled “COLLAPSIBLE CANISTER FOR USE WITH REDUCED PRESSURE THERAPY DEVICE,” filed Mar. 13, 2013, which is incorporated herein by reference for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
1355846 | Rannells | Oct 1920 | A |
2397257 | Goland | Mar 1946 | A |
2547758 | Keeling | Apr 1951 | A |
2632443 | Lesher | Mar 1953 | A |
2682873 | Evans et al. | Jul 1954 | A |
2910763 | Lauterbach | Nov 1959 | A |
2969057 | Simmons | Jan 1961 | A |
3066672 | Crosby, Jr. et al. | Dec 1962 | A |
3367332 | Groves | Feb 1968 | A |
3520300 | Flower, Jr. | Jul 1970 | A |
3568675 | Harvey | Mar 1971 | A |
3648692 | Wheeler | Mar 1972 | A |
3682180 | McFarlane | Aug 1972 | A |
3742952 | Magers | Jul 1973 | A |
3774611 | Tussey | Nov 1973 | A |
3809087 | Lewis, Jr. | May 1974 | A |
3826254 | Mellor | Jul 1974 | A |
3875941 | Adair | Apr 1975 | A |
4080970 | Miller | Mar 1978 | A |
4096853 | Weigand | Jun 1978 | A |
4139004 | Gonzalez, Jr. | Feb 1979 | A |
4165748 | Johnson | Aug 1979 | A |
4184510 | Murry et al. | Jan 1980 | A |
4233969 | Lock et al. | Nov 1980 | A |
4245630 | Lloyd et al. | Jan 1981 | A |
4256109 | Nichols | Mar 1981 | A |
4261363 | Russo | Apr 1981 | A |
4275721 | Olson | Jun 1981 | A |
4284079 | Adair | Aug 1981 | A |
4297995 | Golub | Nov 1981 | A |
4333468 | Geist | Jun 1982 | A |
4373519 | Errede et al. | Feb 1983 | A |
4382441 | Svedman | May 1983 | A |
4392853 | Muto | Jul 1983 | A |
4392858 | George et al. | Jul 1983 | A |
4397643 | Rygiel | Aug 1983 | A |
4419097 | Rowland | Dec 1983 | A |
4429693 | Blake | Feb 1984 | A |
4455140 | Joslin | Jun 1984 | A |
4465485 | Kashmer et al. | Aug 1984 | A |
4475909 | Eisenberg | Oct 1984 | A |
4480638 | Schmid | Nov 1984 | A |
4525166 | Leclerc | Jun 1985 | A |
4525374 | Vaillancourt | Jun 1985 | A |
4529402 | Weilbacher | Jul 1985 | A |
4540412 | Van Overloop | Sep 1985 | A |
4543100 | Brodsky | Sep 1985 | A |
4548202 | Duncan | Oct 1985 | A |
4551139 | Plaas et al. | Nov 1985 | A |
4569348 | Hasslinger | Feb 1986 | A |
4605399 | Weston et al. | Aug 1986 | A |
4608041 | Nielson | Aug 1986 | A |
4640688 | Hauser | Feb 1987 | A |
4655754 | Richmond et al. | Apr 1987 | A |
4664662 | Webster | May 1987 | A |
4710165 | McNeil et al. | Dec 1987 | A |
4733659 | Edenbaum et al. | Mar 1988 | A |
4743232 | Kruger | May 1988 | A |
4758220 | Sundblom et al. | Jul 1988 | A |
4787888 | Fox | Nov 1988 | A |
4826494 | Richmond et al. | May 1989 | A |
4838883 | Matsuura | Jun 1989 | A |
4840187 | Brazier | Jun 1989 | A |
4863449 | Therriault et al. | Sep 1989 | A |
4872450 | Austad | Oct 1989 | A |
4878901 | Sachse | Nov 1989 | A |
4897081 | Poirier et al. | Jan 1990 | A |
4906233 | Moriuchi et al. | Mar 1990 | A |
4906240 | Reed et al. | Mar 1990 | A |
4919654 | Kalt et al. | Apr 1990 | A |
4941882 | Ward et al. | Jul 1990 | A |
4953565 | Tachibana et al. | Sep 1990 | A |
4969880 | Zamierowski | Nov 1990 | A |
4985019 | Michelson | Jan 1991 | A |
5019059 | Goldberg | May 1991 | A |
5037397 | Kalt et al. | Aug 1991 | A |
5086170 | Luheshi et al. | Feb 1992 | A |
5092858 | Benson et al. | Mar 1992 | A |
5100396 | Zamierowski | Mar 1992 | A |
5134994 | Say | Aug 1992 | A |
5149331 | Ferdman et al. | Sep 1992 | A |
5167613 | Karami et al. | Dec 1992 | A |
5176663 | Svedman et al. | Jan 1993 | A |
5215522 | Page et al. | Jun 1993 | A |
5232453 | Plass et al. | Aug 1993 | A |
5248300 | Bryant | Sep 1993 | A |
5261893 | Zamierowski | Nov 1993 | A |
5278100 | Doan et al. | Jan 1994 | A |
5279550 | Habib et al. | Jan 1994 | A |
5298015 | Komatsuzaki et al. | Mar 1994 | A |
5342376 | Ruff | Aug 1994 | A |
5344415 | DeBusk et al. | Sep 1994 | A |
5358494 | Svedman | Oct 1994 | A |
5374257 | Drainville | Dec 1994 | A |
5437622 | Carion | Aug 1995 | A |
5437651 | Todd et al. | Aug 1995 | A |
5451218 | Moore | Sep 1995 | A |
5484428 | Drainville et al. | Jan 1996 | A |
5505717 | Moore | Apr 1996 | A |
5527293 | Zamierowski | Jun 1996 | A |
5549584 | Gross | Aug 1996 | A |
5556375 | Ewall | Sep 1996 | A |
5607388 | Ewall | Mar 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5645081 | Argenta et al. | Jul 1997 | A |
6071267 | Zamierowski | Jun 2000 | A |
6135116 | Vogel et al. | Oct 2000 | A |
6241747 | Ruff | Jun 2001 | B1 |
6287316 | Agarwal et al. | Sep 2001 | B1 |
6345623 | Heaton et al. | Feb 2002 | B1 |
6488643 | Tumey et al. | Dec 2002 | B1 |
6493568 | Bell et al. | Dec 2002 | B1 |
6553998 | Heaton et al. | Apr 2003 | B2 |
6814079 | Heaton et al. | Nov 2004 | B2 |
8535283 | Heaton | Sep 2013 | B2 |
8864748 | Coulthard | Oct 2014 | B2 |
20020077661 | Saadat | Jun 2002 | A1 |
20020115951 | Norstrem et al. | Aug 2002 | A1 |
20020120185 | Johnson | Aug 2002 | A1 |
20020143286 | Tumey | Oct 2002 | A1 |
20060079852 | Bubb et al. | Apr 2006 | A1 |
20090292263 | Hudspeth | Nov 2009 | A1 |
20100030166 | Tout | Feb 2010 | A1 |
20140276488 | Locke | Sep 2014 | A1 |
Number | Date | Country |
---|---|---|
550575 | Mar 1986 | AU |
745271 | Apr 1999 | AU |
755496 | Feb 2002 | AU |
2005436 | Jun 1990 | CA |
26 40 413 | Mar 1978 | DE |
9210829 | Oct 1992 | DE |
43 06 478 | Sep 1994 | DE |
295 04 378 | Oct 1995 | DE |
0048164 | Mar 1982 | EP |
0100148 | Feb 1984 | EP |
0117632 | Sep 1984 | EP |
0161865 | Nov 1985 | EP |
0358302 | Mar 1990 | EP |
1018967 | Aug 2004 | EP |
692578 | Jun 1953 | GB |
2 195 255 | Apr 1988 | GB |
2 197 789 | Jun 1988 | GB |
2 220 357 | Jan 1990 | GB |
2 235 877 | Mar 1991 | GB |
2 329 127 | Mar 1999 | GB |
2 333 965 | Aug 1999 | GB |
4129536 | Apr 1992 | JP |
71559 | Apr 2002 | SG |
8002182 | Oct 1980 | WO |
8704626 | Aug 1987 | WO |
90010424 | Sep 1990 | WO |
9309727 | May 1993 | WO |
94020041 | Sep 1994 | WO |
9605873 | Feb 1996 | WO |
9718007 | May 1997 | WO |
9913793 | Mar 1999 | WO |
Entry |
---|
Partial International Search Report for corresponding PCT/US2014/012822 dated May 9, 2014. |
N.A. Bagautdinov, “Variant of External Vacuum Aspiration in the Treatment of Purulent Diseases of the Soft Tissues,” Current Problems in Modern Clinical Surgery: Interdepartmental Collection, edited by V. Ye Volkov et al. (Chuvashia State University, Cheboksary, U.S.S.R. 1986);pp. 94-96 (certified translation). |
Louis C. Argenta, MD and Michael J. Morykwas, PhD; “Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Animal Studies & Basic Foundation”; Annals of Plastic Surgery, vol. 38, No. 6, Jun. 1997; pp. 553-562. |
Susan Mendez-Eastmen, RN; “When Wounds Won't Heal” RN Jan. 1998, vol. 61 (1); Medical Economics Company, Inc., Montvale, NJ, USA; pp. 20-24. |
James H. Blackburn, II, MD, et al; “Negative-Pressure Dressings as a Bolster for Skin Grafts”; Annals of Plastic Surgery, vol. 40, No. 5, May 1998, pp. 453-457. |
John Masters; “Reliable, Inexpensive and Simple Suction Dressings”; Letters to the Editor, British Journal of Plastic Surgery, 1998, vol. 51 (3), p. 267; Elsevier Science/The British Association of Plastic Surgeons, UK. |
S.E. Greer, et al “The Use of Subatmospheric Pressure Dressing Therapy to Close Lymphocutaneous Fistulas of the Groin” British Journal of Plastic Surgery (2000), vol. 53, pp. 484-487. |
George V. Letsou, MD., et al; “Stimulation of Adenylate Cyclase Activity in Cultured Endothelial Cells Subjected to Cyclic Stretch”; Journal of Cardiovascular Surgery, vol. 31, 1990, pp. 634-639. |
Orringer, Jay, et al; “Management of Wounds in Patients with Complex Enterocutaneous Fistulas”; Surgery, Gynecology & Obstetrics, Jul. 1987, vol. 165, pp. 79-80. |
International Search Report for PCT International Application PCT/GB95/01983; dated Nov. 23, 1995. |
PCT International Search Report for PCT International Application PCT/GB98/02713; dated Jan. 8, 1999. |
PCT Written Opinion; PCT International Application PCT/GB98/02713; dated Jun. 8, 1999. |
PCT International Examination and Search Report, PCT International Application PCT/GB96/02802; dated Jan. 15, 1998 & Apr. 29, 1997. |
PCT Written Opinion, PCT International Application PCT/GB96/02802; dated Sep. 3, 1997. |
Dattilo, Philip P., Jr., et al; “Medical Textiles: Application of an Absorbable Barbed Bi-directional Surgical Suture”; Journal of Textile and Apparel, Technology and Management, vol. 2, Issue 2, Spring 2002, pp. 1-5. |
Kostyuchenok, B.M., et al; “Vacuum Treatment in the Surgical Management of Purulent Wounds”; Vestnik Khirurgi, Sep. 1986, pp. 18-21 and 6 page English translation thereof. |
Davydov, Yu. A., et al; “Vacuum Therapy in the Treatment of Purulent Lactation Mastitis”; Vestnik Khirurgi, May 14, 1986, pp. 66-70, and 9 page English translation thereof. |
Yusupov. Yu. N., et al; “Active Wound Drainage”, Vestnik Khirurgi, vol. 138, Issue 4, 1987, and 7 page English translation thereof. |
Davydov, Yu. A., et al; “Bacteriological and Cytological Assessment of Vacuum Therapy for Purulent Wounds”; Vestnik Khirurgi, Oct. 1988, pp. 48-52, and 8 page English translation thereof. |
Davydov, Yu. A., et al; “Concepts for the Clinical-Biological Management of the Wound Process in the Treatment of Purulent Wounds by Means of Vacuum Therapy”; Vestnik Khirurgi, Jul. 7, 1980, pp. 132-136, and 8 page English translation thereof. |
Chariker, Mark E., M.D., et al; “Effective Management of incisional and cutaneous fistulae with closed suction wound drainage”; Contemporary Surgery, vol. 34, Jun. 1989, pp. 59-63. |
Egnell Minor, Instruction Book, First Edition, 300 7502, Feb. 1975, pp. 24. |
Egnell Minor: Addition to the Users Manual Concerning Overflow Protection—Concerns all Egnell Pumps, Feb. 3, 1983, p. 1. |
Svedman, P.: “Irrigation Treatment of Leg Ulcers”, The Lancet, Sep. 3, 1983, pp. 532-534. |
Chinn, Steven D. et al.: “Closed Wound Suction Drainage”, The Journal of Foot Surgery, vol. 24, No. 1, 1985, pp. 76-81. |
Arnljots, Björn et al.: “Irrigation Treatment in Split-Thickness Skin Grafting of Intractable Leg Ulcers”, Scand J. Plast Reconstr. Surg., vol. 19, 1985, pp. 211-213. |
Svedman, P.: “A Dressing Allowing Continuous Treatment of a Biosurface”, IRCS Medical Science: Biomedical Technology, Clinical Medicine, Surgery and Transplantation, vol. 7, 1979, p. 221. |
Svedman, P. et al.: “A Dressing System Providing Fluid Supply and Suction Drainage Used for Continuous or Intermittent Irrigation”, Annals of Plastic Surgery, vol. 17, No. 2, Aug. 1986, pp. 125-133. |
K.F. Jeter, T.E. Tintle, and M. Chariker, “Managing Draining Wounds and Fistulae: New and Established Methods,” Chronic Wound Care, edited by D. Krasner (Health Management Publications, Inc., King of Prussia, PA 1990), pp. 240-246. |
G. {hacek over (Z)}ivadinovic, V. Ðukić, {hacek over (Z)}. Maksimović, Ð. Radak, and P. Pe{hacek over (s)}ka, “Vacuum Therapy in the Treatment of Peripheral Blood Vessels,” Timok Medical Journal 11 (1986), pp. 161-164 (certified translation). |
F.E. Johnson, “An Improved Technique for Skin Graft Placement Using a Suction Drain,” Surgery, Gynecology, and Obstetrics 159 (1984), pp. 584-585. |
A.A. Safronov, Dissertation Abstract, Vacuum Therapy of Trophic Ulcers of the Lower Leg with Simultaneous Autoplasty of the Skin (Central Scientific Research Institute of Traumatology and Orthopedics, Moscow, U.S.S.R. 1967) (certified translation). |
M. Schein, R. Saadia, J.R. Jamieson, and G.A.G. Decker, “The ‘Sandwich Technique’ in the Management of the Open Abdomen,” British Journal of Surgery 73 (1986), pp. 369-370. |
D.E. Tribble, “An Improved Sump Drain-Irrigation Device of Simple Construction,” Archives of Surgery 105 (1972) pp. 511-513. |
C.E. Tennant, “The Use of Hypermia in the Postoperative Treatment of Lesions of the Extremities and Thorax,” Journal of the American Medical Association 64 (1915), pp. 1548-1549. |
Selections from W. Meyer and V. Schmieden, Bier's Hyperemic Treatment in Surgery, Medicine, and the Specialties: A Manual of Its Practical Application, (W.B. Saunders Co., Philadelphia, PA 1909), pp. 17-25, 44-64, 90-96, 167-170, and 210-211. |
V.A. Solovev et al., Guidelines, The Method of Treatment of Immature External Fistulas in the Upper Gastrointestinal Tract, editor-in-chief Prov. V.I. Parahonyak (S.M. Kirov Gorky State Medical Institute, Gorky, U.S.S.R. 1987) (“Solovev Guidelines”). |
V.A. Kuznetsov & N.A. Bagautdinov, “Vacuum and Vacuum-Sorption Treatment of Open Septic Wounds,” in II All-Union Conference on Wounds and Wound Infections: Presentation Abstracts, edited by B.M. Kostyuchenok et al. (Moscow, U.S.S.R. Oct. 28-29, 1986) pp. 91-92 (“Bagautdinov II”). |
V.A. Solovev, Dissertation Abstract, Treatment and Prevention of Suture Failures after Gastric Resection (S.M. Kirov Gorky State Medical Institute, Gorky, U.S.S.R. 1988) (“Solovev Abstract”). |
V.A.C.® Therapy Clinical Guidelines: A Reference Source for Clinicians (Jul. 2007). |
Number | Date | Country | |
---|---|---|---|
20140276488 A1 | Sep 2014 | US |
Number | Date | Country | |
---|---|---|---|
61780056 | Mar 2013 | US |